ARTICLE | Company News
Management tracks: Trevena, Galecto
May 22, 2018 9:59 PM UTC
Neurology company Trevena Inc. (NASDAQ:TRVN) hired Mark Demitrack as SVP and CMO. He was VP of clinical strategy at Roivant Sciences GmbH (Basel, Switzerland).
Galectin modulator company Galecto Biotech AB (Copenhagen, Denmark) hired Richard Marshall as CMO. He was VP and head of the fibrosis and lung injury discovery performance unit at GlaxoSmithKline plc (LSE:GSK; NYSE:GSK)...